TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Faun Pharma AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
115,534
|
104,185
|
98,660 |
| Financial expenses |
355
|
394
|
201 |
| Earnings before taxes |
4,948
|
4,200
|
1,999 |
| Total assets |
38,939
|
33,302
|
32,217 |
| Current assets |
31,409
|
26,337
|
24,083 |
| Current liabilities |
9,279
|
7,232
|
7,875 |
| Equity capital |
21,819
|
18,889
|
16,612 |
| - share capital |
630
|
663
|
706 |
| Employees (average) | 41 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
56.0%
|
56.7%
|
51.6% |
| Turnover per employee | 2,406 | ||
| Profit as a percentage of turnover |
4.3%
|
4.0%
|
2.0% |
| Return on assets (ROA) |
13.6%
|
13.8%
|
6.8% |
| Current ratio |
338.5%
|
364.2%
|
305.8% |
| Return on equity (ROE) |
22.7%
|
22.2%
|
12.0% |
| Change turnover |
16,579
|
11,587
|
-15,732 |
| Change turnover % |
17%
|
13%
|
-14% |
| Chg. No. of employees | 3 | ||
| Chg. No. of employees % | 8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.